Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis

View ORCID ProfileZachary J. Williams
doi: https://doi.org/10.1101/2021.07.13.21260452
Zachary J. Williams
1Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, TN
2Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, Nashville, TN
3Vanderbilt Brain Institute, Vanderbilt University, Nashville, TN
4Frist Center for Autism and Innovation, Vanderbilt University, Nashville, TN
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zachary J. Williams
  • For correspondence: Zachary.j.williams{at}vanderbilt.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background and Objectives Strabismus, a misalignment of the eyes, is an important risk factor for amblyopia and visual impairment in the pediatric population. Several studies have reported an increased likelihood of strabismus in persons on the autism spectrum, but prevalence estimates in this group vary greatly.

Methods We searched multiple databases to identify peer-reviewed articles published in English through November 1, 2020 that provided estimates of strabismus prevalence in autistic individuals. Prevalence estimates were synthesized using Bayesian random-effects meta-analysis, and sensitivity analysis was also performed using only the subset of studies that recruited participants from non-ophthalmologic settings and identified strabismus using structured ocular exams. Bayesian meta-regression was used to assess potential moderators of prevalence across studies.

Results A total of 151 nonduplicate articles were screened, of which 22 were included in the meta-analysis (k=28 samples, nAUT=113,227). The meta-analytic point prevalence of strabismus in autistic individuals was 13.4% (95% CrI [8.3,19.4]), and sensitivity analysis produced a very similar estimate (14.0% [7.0,22.0], nAUT=581). Esotropia was the predominant subtype of strabismus reported, accounting for approximately 55% of cases. Reported prevalence rates were higher in younger samples (BF10=13.43, R2Het =0.273) and samples recruited from optometry/ophthalmology clinics (BF10=11.47, R2Het =0.238).

Conclusion This meta-analysis found a high prevalence of strabismus in autistic individuals, with rates 3–10 times that of the general population. As untreated strabismus is a major risk factor for amblyopia in young children, these findings underscore the importance of timely screening and assessment of ocular problems in persons on the autism spectrum.

What’s Known on This Subject Strabismus has been reported to be more prevalent in individuals on the autism spectrum, but estimates have been very imprecise, ranging from 3–84% across studies.

What This Study Adds This study performs the first quantitative synthesis of strabismus prevalence in over 100,000 autistic individuals, generating more precise estimates of the prevalence of strabismus in the autistic population. Factors contributing to the large differences between studies are also examined using meta-regression.

Competing Interest Statement

Zachary Williams has served as a consultant for Roche. He is also a family partner for the Autism Speaks Autism Care Network Vanderbilt site and a member of the autistic researcher review board of the Autism Intervention Research Network on Physical Health (AIR-P).

Funding Statement

This study was supported by National Institute of General Medical Sciences grant T32-GM007347, National Institute on Deafness and Other Communication Disorders grant F30-DC019510, and the Nancy Lurie Marks Family Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The meta-analysis was considered "non-human subjects research" and was therefore exempt from IRB approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of Interest Disclosures (includes financial disclosures): Zachary Williams has served as a consultant for Roche. He is also a family partner for the Autism Speaks Autism Care Network Vanderbilt site and a member of the autistic researcher review board of the Autism Intervention Research Network on Physical Health (AIR-P).

  • Funding/Support: This study was supported by National Institute of General Medical Sciences grant T32-GM007347, National Institute on Deafness and Other Communication Disorders grant F30-DC019510, and the Nancy Lurie Marks Family Foundation.

  • Role of Funder/Sponsor: No funding body or source of support had a role in the study design, data collection, analysis, or interpretation, decision to publish, or preparation of this article.

Data Availability

Original data used in the meta-analysis can be found in the primary articles, as well as supplemental table 1.

  • Abbreviations

    BF10
    Bayes factor comparing meta-regression model to baseline model
    CrI
    Highest-density credible interval
    DQ
    Developmental quotient
    IQ
    Intelligence quotient
    IQR
    Interquartile range
    Mdn
    Median
    nAUT
    Number of individuals diagnosed with autism in a study
    nStrabismus
    Number of autistic individuals diagnosed with strabismus in a study
    R2Het
    Proportion of heterogeneity explained by moderator
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 16, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis
    Zachary J. Williams
    medRxiv 2021.07.13.21260452; doi: https://doi.org/10.1101/2021.07.13.21260452
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Prevalence of Strabismus in Individuals on the Autism Spectrum: A Meta-analysis
    Zachary J. Williams
    medRxiv 2021.07.13.21260452; doi: https://doi.org/10.1101/2021.07.13.21260452

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Ophthalmology
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)